Sir, We read with great interest the article by Uzuner and Ziessman [1] . The authors studied an 11-year-old girl with protein-losing enteropathy (PLE) and concluded that intestinal accumulation of Tc-99m methylene diphosphonate (MDP) was useful for confirming the diagnosis.
Diagnosis of PLE is usually cumbersome and in some cases diagnostic work-up is inconclusive. Therefore, functional imaging modalities are of great importance. In-111 transferrin, Tc-99m human immunoglobulin, Tc-99m dextran and Tc-99m human serum albumin have been used to evaluate PLE. The latter radionuclide is an ideal tracer, because of its low false-positive index, high sensitivity and the absence of serious side effects [2] . Moreover, sequential imaging up to 24 h may enhance the diagnostic value of the study, probably due to the intermittent nature of protein loss. Intestinal accumulation of bone-seeking radiotracers is exceedingly rare but continues to be reported in the medical literature, mainly as an incidental finding when evaluating musculoskeletal pathology, and may pinpoint the diagnosis [3] . Although the precise mechanism of intestinal uptake of Tc-99m-MDP remains uncertain, binding of this radiopharmaceutical to plasma proteins is thought to play a critical role. Inadequate radiopharmaceutical preparation Tc-99m pertechnetate characteristically leads to its uptake in the stomach, bowel, salivary glands and thyroid. Ergün et al. [4] did not find any specific cause of intestinal accumulation of Tc-99m-MDP in the majority of their patients. They suggested that this may be an intermittent process. Based on our own experience (one already reported [3] ), Tc-99m-MDP imaging in patients with PLE shows enhanced abdominal accumulation of Tc-99m-MDP due to an increase in the extracellular volume of distribution of the tracer, because of anasarca, but does not allow better localization of the leakage site. Views obtained after 2 h correspond to the findings of Tc-99m human serum albumin scans.
Radiopharmaceuticals for functional imaging of PLE are not widely available; the diagnosis of PLE cannot be established with Tc-99m-MDP. Nevertheless, intestinal Tc-99m-MDP uptake combined with medical history and clinical assessment may help to diagnose systemic disease.
